Workflow
OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting
Newsfile·2025-10-09 19:40
          OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur MeetingOctober 09, 2025 7:40 AM EDT | Source: OS TherapiesOverall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care existsRapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of PennsylvaniaNew York, New York--(Newsfile Corp. - October 9, 2025) - OS Therapies In ...